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What´s already known about this topic? 
• Caffeine stimulates hair growth in androgen-sensitive testosterone-suppressed male human hair 
follicles (HFs) in vitro. 
 
What does the study add? 
• First evidence for caffeine-stimulated growth of female human HFs; more caffeine-sensitive than 
male HFs.  
• Proliferation increase by caffeine in human HF matrix keratinocytes in situ and HF-derived outer 
root sheath keratinocytes (ORSK). 
• Down-regulation of catagen-inducer TGF-β2 and up-regulation of anagen-promoting factor IGF-1 
in human HFs in situ and in ORSK. 
 
Abstract  
Background Caffeine reportedly counteracts the suppression of hair shaft production by 
testosterone in organ-cultured male human hair follicles (HFs). 
Objectives We aimed at investigating the impact of caffeine a) on additional key hair growth 
parameters, b) on major hair growth-regulatory growth factors and c) on male versus female HFs in 
the presence of testosterone. 
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Methods Microdissected male and female human scalp HFs were treated in serum-free organ 
culture for 120 h with testosterone alone (0,5 µg/ml) or in combination with caffeine (0.005–
0.0005%), and effects on hair shaft elongation, HF cycling (i.e. anagen–catagen transition), hair 
matrix keratinocyte proliferation and expression of a key catagen inducer, transforming growth 
factor β2 (TGF-β2), and anagen-prolonging insulin-like growth factor 1 (IGF-1) were evaluated by 
quantitative (immuno-) histomorphometry. Caffeine effects were further investigated in human 
outer root sheath keratinocytes (ORSK). 
Results Caffeine enhanced hair shaft elongation, prolonged anagen duration and stimulated hair 
matrix keratinocyte proliferation. Female HFs showed higher sensitivity to caffeine compared to 
male HFs. Caffeine counteracted testosterone-enhanced TGF-β2 protein expression in male HFs. In 
female HFs, testosterone failed to induce TGF-β2 expression, while caffeine reduced it. In male and 
female HFs, caffeine enhanced IGF-1 protein expression. In ORSK, caffeine stimulated cell 
proliferation, inhibited apoptosis/necrosis, up-regulated IGF-1 gene expression and protein 
secretion, while TGF-β2 protein secretion was down-regulated. 
Conclusions This study reveals new growth-promoting effects of caffeine on human hair follicles of 
both genders at different (molecular, cellular and organ) levels. 
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Introduction 
Caffeine is a well-known stimulant contained in coffee, whose effects mainly are mediated 
through inhibition of phosphodiesterase. This leads to increased intracellular adenylate 
cyclase activity and enhanced cyclic 3´,5´-adenosine mono-phosphate (cAMP) levels, 
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therefore providing higher energy levels to promote increased metabolic activity and cell 
proliferation1. Little is as yet known about the effects of caffeine on human hair follicle (HF) 
growth, but it has been hypothesiszed that caffeine may counteract HF miniaturization in 
patiens with androgenetic alopecia (AGA)2. Although approximately 50% of men at the age 
of 50 years suffer from AGA3-5, there are still only two FDA-approved drugs available for AGA 
management treatment, namely finasterid and minoxidil3. Therefore, development of 
additional effective treatment strategies seems to be a reasonable need.  
Dihydrotestostone (DHT) is the testosterone-derived, AGA-promoting androgen that causes 
a continuous shortening of hair growth cycles (anagen) in favor of longer resting phases 
(telogen), along with HF miniaturization of genetically predetermined areas in the fronto-
temporal and vertex region of men affected with AGA6-9. Since testosterone inhibits 
adenylate cyclase activity in human HFs6, we hypothesized that caffeine may counteract the 
DHT-induced growth inhibition of human androgen-sensitive scalp HFs.  
So far, caffeine has been shown to reverse the inhibitory effect of testosterone on 
keratinocyte proliferation in a male skin organ culture model (MSOCM)7 and to normalize 
the testosterone-induced inhibition of hair shaft elongation and to stimulate hair matrix 
keratinocyte proliferation in organ-cultured human HFs2. In the current study, we have 
extended this line of research by examining whether caffeine also impacts on human HF 
cycling, hair matrix apoptosis and the expression of two major antagonistic hair growth-
regulatory growth factors, i.e., transforming growth factor β2 (TGF-β2) and insulin-like 
growth factor 1 (IGF-1) as well as its effects on isolated human HF-derived outer root sheath 
keratinocytes (ORSK). In addition, we have compared the effects of caffeine on male versus 
female HFs in the presence of testosterone. 
 
This article is protected by copyright. All rights reserved. 
Materials and methods 
Human hair follicle culture 
Whole human HFs (anagen VI) were microdissected from biopsies from women undergoing face-lift 
surgery, and male HFs were obtained from electively taken biopsies (0.5×1.5 cm) from the balding 
vertex region in the border area of the dense to the shedding area (androgen-sensitive) of men 
affected with AGA in moderate stage (Norwood-Hamilton stage III vertex and IV5). The study was 
approved by the Ethics Committee of the University of Lübeck (reference 06-109) and written 
informed consent was obtained from the patients in accordance with the “Helsinki Declaration”. 
HF extraction and cultivation in the established HF organ culture model was performed as previously 
described2,8,9. After 24 h recovery time in serum-free, supplemented William’s E medium, 
experiments were started by replacing normal medium with fresh medium containing a) 
testosterone alone or b) testosterone in combination with caffeine or c) normal growth medium as 
control. Control and treatment media were changed every other day and total culture time was 120 
h. Testosterone was used in the concentration of 0.5 µg/ml and caffeine at concentrations of 0.005% 
and 0.001% in order to permit comparison with earlier work2. After the first experiments with 
female HFs, the concentration of caffeine was lowered to 0.0005% due to observed higher 
responsiveness of female HFs to this concentration. Hair shaft elongation was measured every 24 h 
by using a scaled microscopic eyepiece. After 120 h, follicles were frozen at –80° C, and 6 µm 
cryosections were processed for immunohistochemistry and immuno-fluorescence as described 
previously8,10. 
 
Hair follicle immunohistochemistry and immunofluorescence microscopy 
HFs were stained with hematoxylin-eosin for assessment of HF morphology and hair cycle phase 
(anagen, catagen)10. The hair cycle score was calculated as described earlier11.  
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Proliferation and apoptosis were assessed by Ki67/TUNEL double-immunostaining as reported 
before12.  
To detect the in situ protein expression of the key-catagen inductor TGF-β2 and one major growth 
factor IGF-1, immunofluorescence with tyramide signal amplification (TSA) was performed using the 
polyclonal rabbit anti-TGF-β2 IgG (1:4000) and the polyclonal goat anti-IGF-1 IgG (1:500) antibody, 
respectively (both from Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) (for staining protocol 
details see supplementary file 1).  
 
Proliferation and apoptosis/necrosis in human HF-derived outer root sheath keratinocytes 
Human plucked eyebrow HFs of several male healthy donors were obtained after written informed 
consent adhering to Helsinki guidelines and after Institutional Research Ethics Committee 
permission. Outer root sheath keratinocytes (ORSK) were then isolated and cultured under 
optimized conditions as previously described13-15 (for detailed description see also supplementary 
file 1). ORSK were then treated with caffeine (0.00001%, 0.0001%, 0.001%; Azelis, Antwerpen, 
Belgium) and positive stimulatory reference agents such as IGF-1 (100 ng/ml) and minoxidil (0.1 
μM)8 as well as the negative regulatory reference substance tretinoin (1 μM) (all from Sigma-Aldrich, 
St. Louis, MO, USA) for 24, 48, 72 and 96 h15. Cellular proliferation under these different treatment 
conditions was quantified by using CyQUANT Cell Proliferation Assay Kit (Invitrogen, Paisley, UK) and 
additionally assessed by immunocytochemical labeling of the proliferation nuclear marker Ki67 as 
described previously13,16 (see also supplementary file 1).  
Caffeine was further investigated for protective effects against apoptosis- and necrosis-inducing 
agents such as catagen inducers which, in vivo, may induce clinically relevant hair loss. For this 
purpose, two strong catagen inducers, TGF-β2 (50 ng/ml) (Sigma-Aldrich)17 and anandamide (AEA; 
30 μM) (Cayman, Ann Arbor, MI, USA)18 were applied for 24 or 48 h in ORSK culture. In parallel, 
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three concentrations of caffeine or catagen-inhibitory agents, i.e. IGF-1 (100 ng/ml) and keratinocyte 
growth factor (KGF; 20 ng/ml) (both from Sigma-Aldrich)19,20 were applied for 1 h to induce anti-
apoptotic/-necrotic effects. Mitochondrial membrane potential reduction as early marker of 
apoptosis was determined using a MitoProbe DiIC1 (5) Assay Kit (Invitrogen) following previously 
optimized protocols16,21 (see supplementary file 1). Necrotic cell death was determined by Sytox 
Green nucleic acid staining (Invitrogen) as described previously16,21 (see supplementary file 1).  
 
TGF-β2 and IGF-1 gene expression (Q-PCR) and protein secretion (ELISA) in ORSK 
To determine the quantitative gene expressions of TGF-β2 and IGF-1 from cell lysates of ORSK after 
120 h stimulation with caffeine (0.00001%, 0.0001%, 0.001%) and positive stimulatory reference 
agents (IGF-1: 100 ng/ml; minoxidil: 0.1 μM) as well as the negative regulatory reference substance 
tretinoin (1 μM), Q-PCR was performed on an ABI Prism 7000 sequence detection system (Applied 
Biosystems, Foster City, CA, USA) using the 5’ nuclease assay as detailed in our previous reports16,22,23 
(see also supplementary file 1). The supernatants of ORSK treated with the above mentioned 
substances were taken at 24, 72 and 120 h for quantitative determination of TGF-β2 and IGF-1 
protein levels using specific ELISA kits (R&D Systems, Minneapolis, MN, USA) following the protocol 
of the manufacturer. 
 
Statistical analysis 
Data were expressed as means ±SEM of pooled data from independent experiments for each study 
parameter. Values were normalized and expressed as percentage of control. All data were analyzed 
with GraphPad Prism 5.02 software (La Jolla, CA, USA) using Student’s t-test for independent 
samples. A p-value of <0.05 was considered statistically significant. 
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Results 
Male and female hair shaft elongation is differently stimulated by caffeine 
Hair shaft elongation of male HFs revealed the same concentrations of 0.005% and 0.001% caffeine 
to be stimulatory effective as shown in previous experiments2 (data not shown). For the first female 
HFs experiments, the same concentrations failed to promote hair shaft elongation. Therefore, the 
caffeine concentration was reduced to 0.0005% in the following experiments. This significantly 
counteracted the testosterone-induced inhibition of hair shaft elongation at 120 h (p<0.05) (Fig. 1).  
 
Hair matrix keratinocyte proliferation is enhanced by caffeine  
Caffeine (0.001%) significantly increased the number of Ki67-positive hair matrix keratinocytes 
compared to testosterone- or vehicle-treated control male HFs (*p<0.05; **p<0.01) (Fig. 2A,B). In 
female HFs, vehicle-treated control HFs revealed 39% Ki67-positive matrix keratinocytes, the 
testosterone-treated hair follicles showed only 19% (p<0.05) and caffeine (0.0005%) increased the 
percentage of Ki67-positive matrix keratinocytes up to 30% (Fig. 2C,D).  
 
Caffeine stimulates cellular proliferation in ORSK 
Over 96 h, a significant pro-proliferative effect of caffeine was observed in ORSK by CyQUANT assay. 
This effect was most prominent at 24 h and exerted by all applied caffeine concentrations (0.00001, 
0.0001, 0.001%) reaching up to 160% compared to 100% control (p<0.05) (Fig. 3A). The positive 
control IGF-1 (100 ng/ml) lead also to a significant, but less expressed increase of proliferation 
compared to control (ca. 140%; p<0.05). Minoxidil, the second positive control, lead to comparable 
growth enhancement (ca. 140%; p<0.05), but again, less expressed than caffeine. The growth-
inhibitory negative standard tretinoin (1 µM) did not lead to any change of proliferation. At 48 h, 
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caffeine at 0.00001% and 0.0001% lead to stimulation of proliferation (ca. 120 and 130%, 
respectively), however, only 0.0001% reached significance (p<0.05) (Fig. 3B). IGF-1 significantly 
stimulated proliferation as well (ca. 130%; p<0.05), but minoxidil not. At 72 h, only IGF-1 showed a 
significant pro-proliferative effect (p<0.05) (Fig. 3C), while at 96 h there was no effect of any 
substance (Fig. 3D). 
Immunofluorescence-cytochemical labeling of proliferating Ki67-positive ORSK confirmed the data 
assessed by CyQUANT. Namely, incubation of ORS keratinocytes with caffeine for 24 h leads to a 
significantly higher, caffeine dose-dependent percentage of Ki67-positive cells as compared to 
vehicle-treated control. (Fig. 4A,B). 
 
Caffeine inhibits apoptosis and necrosis in ORSK 
In TGF-β2-treated ORSK, there was a biologically relevant and significant induction of apoptosis, 
indicated by decreased DilC1 (5) signal, and necrosis, as shown by Sytox Green increase, as well 
(p<0.05). This was significantly counteracted after 48 h incubation with caffeine at the concentration 
of 0.0001% (only necrosis) and 0.001% as well as by IGF-1 and KGF (p<0.05) (Fig. 5A, right columns). 
In anandamide-treated ORSK, similar protective effects of caffeine, IGF-1 and KGF were observed; 
however significant suppression of apoptosis and necrosis by caffeine were exclusively observed at 
the concentration of 0.001% (Fig. 5B, right columns). 
 
Anagen-stage suppression by testosterone is counteracted by caffeine in male and partly in female 
hair follicles  
As expected, testosterone reduced the percentage of male HFs in anagen VI to 39% compared to 
56% in controls after 120 h of HF organ culture. Co-incubation with caffeine (0.001%) strikingly 
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raised the percentage of anagen HF percentage up to 70% (Fig. 6A). A similar, though less 
pronounced effect of caffeine was also seen in female HFs at the concentrations 0.001% and 
0.0005%, respectively (Fig. 6B). These findings were independently corroborated for male HFs by 
analysing the hair cycle score (Fig. 6C). In female HFs, the hair cycle score showed higher values in 
testosterone treated HFs, while HFs co-cultivated with caffeine 0.0005% showed no decrease (Fig. 
6D).  
 
Caffeine differentially modulates intrafollicular TGF-β2 and IGF-1 protein expression 
TGF-β2-immunoreactivity (IR) in situ was not only detected in the outer root sheath (ORS) of the 
HF18, but also in the Henle-layer of the inner root sheath (IRS). In male human HFs, testosterone 
significantly up-regulated intrafollicular protein expression of the catagen-promoting growth factor, 
TGF-β2 (p<0.05) (Fig. 7A,B). Caffeine 0.001% significantly reduced the TGF-β2 expression down to 
normal (control) levels (98%; p<0.01). In female HFs, testosterone did not significantly up-regulate 
TGF-β2 protein expression, while co-culture with caffeine (0.0005%) significantly reduced IGF-1 IR 
(p<0.01) (Fig. 7C,D).  
IGF-1 IR was detected in both the ORS and IRS (Fig. 8A). Protein expression of IGF-1 in male HFs was 
significantly reduced by testosterone (p<0.05), whereas co-culture with caffeine (0.001%) 
significantly up-regulated IGF-1 IR compared to testosterone- (p<0.001) or vehicle-treated control 
HFs (p<0.01) (Fig. 8B). In female HFs, IGF-1 was not consistently regulated by testosterone (data not 
shown), but in HFs treated with caffeine alone, there was a stimulation of IGF-1 expression which 
was significant for the concentrations of 0.005% and 0.001% (p<0.001 and p<0.01, respectively) (Fig. 
8C,D). At the concentration 0.0005%, caffeine did not modulate IGF-1 expression (data not shown).  
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TGF-β2 and IGF-1 gene expression and protein secretion in male ORSK is partly modulated by 
caffeine 
TGF-β2 mRNA transcripts were detected in ORSK from all 6 male donors, however, no gene 
regulation by caffeine in any concentration was observed (data not shown).  
Specific mRNA transcripts of IGF-1 were below the detection limit in ORSK from three out of six male 
donors (data not shown), whereas in the other three donors, IGF-1 was detected (albeit at very low 
levels) (Fig. 9). Interestingly, caffeine (applied for 120 h) exerted mixed effects: in two donors, 
caffeine (0.001%) significantly up-regulated IGF-1 gene expression (p<0.05) (Fig. 9A,C), while in the 
third donor, IGF-1 gene expression was not regulated by caffeine at any concentration (Fig. 9B). 
Analysis of cellular TGF-β2 and IGF-1 secretion assessed by ELISA from cell supernatants detected 
both substances. Intriguingly, caffeine did not modify levels of TGF-β2 up to 72 h (Fig. 10A,B). Yet, in 
one out of three donors at 120 h incubation time, the concentration of 0.001% significantly 
suppressed TGF-β2 secretion compared to control (p<0.05) (Fig. 10C). Corresponding to known 
effects of tretinoin, this standard catagen inducer significantly up-regulated TGF-β2 secretion at 72 
and 120 h in two donors (p<0.05) (Fig. 10B,C).  
Regarding IGF-1 detection, caffeine at the concentration of 0.001% (identical in all 3 male donors) 
lead to increased IGF-1 secretion at all time-points investigated (24, 72, 120 h) (Fig. 10D,E,F). IGF-1 
itself, added externally to the HF culture as an internal control (100 ng/ml), could also be detected at 
all investigated time points (24, 72, 120 h) at high levels and significantly different from the control 
(p<0.05).  
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Discussion  
The current study reveals potent, differential hair growth-stimulatory effects on scalp HFs from both 
genders that substantially extend beyond the previous literature11,12 and examines for the first time 
also caffeine effects on female HFs. Caffeine enhances hair shaft elongation, prolongs anagen 
duration and stimulates hair matrix keratinocyte proliferation, with female HFs showing a higher 
sensitivity to caffeine than male HFs. Caffeine counteracts testosterone-enhanced TGF-β2 protein 
expression in male HFs and reduces TGF-β2 expression in female HFs, while it enhances 
intrafollicular IGF-1 protein expression in both genders. That these caffeine effects can essentially 
also be seen in isolated ORSK further supports the overall concept that caffeine may be a genuine 
hair growth-stimulatory agent.  
The current data are well in line with earlier reports that show caffeine counteracting the growth-
suppressive effect of testosterone on epidermal keratinocyte proliferation7 and testosterone-
induced human skin barrier function in vivo24. That the most effective caffeine concentration in male 
HFs was 0.001%, independently confirms our previously published results2, while the increased 
caffeine sensitivity of female scalp HFs is revealed here for the first time. It remains rather 
speculative whether or not this is due to gender-dependent differences in putative caffeine target 
molecules25.  
The influence of caffeine on two key hair growth-regulatory factors, TGF-β2 (catagen promotion)11,17 
and IGF-1 (anagen maintenance)9,17,20,26,27 demonstrated here for the first time, corresponds well to 
related caffeine effects described in other systems: Caffeine exerts protective effects in a rat 
cirrhosis model by reducing TGF-β2 serum levels28,29 and inhibits TGF-β-stimulated connective tissue 
growth factor expression in hepatocytes30. Caffeine also reduces oxidized glutathione and TGF-β1 
protein expression during experimentally induced rat liver injury31.  
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In our study, caffeine stimulated also the in situ protein expression, gene expression and protein 
secretion of IGF-1 in human HFs and/or ORSK. This is in line with the observation in 
pancreatectomized diabetic rats that showed long-term caffeine supplementation to potentiate an 
insulin/IGF-1 signaling cascade leading to an alleviation of insulin resistance by improved glucose 
metabolism32. Given that serum-free human HF organ culture requires insulin supplementation of 
the medium9, increased cellular insulin sensitivity might also underlie the caffeine-induced 
stimulation of IGF-1 expression, along with hair growth stimulation, observed in the current study. 
IGF-1 stimulation by caffeine may even counteract human HF aging as represented by reduced hair 
diameter and density33,34, since relative IGF-1 deficiency may occur with increasing age as a result of 
reduced systemic IGF-1 levels35.    
Here we show that caffeine increases proliferation and reduces apoptosis of human ORSK. Similar 
caffeine effects have been described in murine vascular smooth muscle cells revealing 
concentration-dependent stimulatory effects on cell proliferation, protection against apoptosis and 
reduction of reactive oxygen species36. Since caffeine also reduces reactive nitrogen species and 
serum levels of the oxidatively damaged DNA adduct 8-oxo-guanine in fat-fed ApoE(-/-) mice in 
vivo36, and caffeine-containing extracts from roasted coffee protect against lipid peroxidation and 
protein oxidation by directly scavenging free radicals and reducing ferrous ions37, caffeine may well 
exert complex antioxidative protective properties also in human HFs. Finally, mitochondrial function 
is also increased by caffeine38 which may further protect against HF aging and generally support HF 
growth.  
Given that dermal papilla fibroblasts from men with AGA display a higher sensitivity to oxidative 
stress than those from non-balding men39, caffeine might counteract AGA progression in men on 
several different levels, not only by enhancing intrafollicular cAMP and IGF-1 levels and reducing 
TGF-β2 expression, but also by reducing oxidative stress in genetically predisposed balding HFs. Our 
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study suggests that these putative AGA-protective effects of caffeine may also be clinically relevant 
in women.  
In summary, the in vitro data in ORSK and human whole HFs presented are just opening a new 
chapter of the complex and obviously pluripotent role of caffeine in human hair biology. They 
strongly support the concept that caffeine is a credible hair growth-promoting and HF-protective 
substance that deserves further in vitro as well as in vivo exploration.  
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Legends to Figures 
Fig. 1:  
Hair shaft elongation in female hair follicles at 120 h of hair follicle culture. 
Testosterone (T) significantly suppressed hair shaft elongation in female human hair follicles down to 
77%, and co-cultivation with caffeine (T + C 0.0005%) significantly enhanced hair shaft elongation up 
to 96% compared to 100% control. Data are presented as mean ±SEM. *p<0.05, **p<0.01. 
 
Fig. 2:  
Hair matrix keratinocyte proliferation 
Testosterone showed a slight inhibition of Ki67-positive matrix keratinocytes in male hair follicles 
assessed by immuno-fluorescence (A), and caffeine 0.001% significantly increased the number of 
Ki67-positive matrix keratinocytes compared to testosterone and to control (B). Proliferation in 
female hair follicles showed a significant suppression of the number of Ki67-positive matrix 
keratinocytes by testosterone, and caffeine (0.0005%) induced a higher percentage of proliferating 
Ki67 matrix keratinocytes in hair follicles co-cultured with caffeine (C,D). #1, #2 and #3 are 
exemplary images of the different treatment conditions from the HF from three different individuals. 
Data are presented as mean ±SEM. *p<0.05. 
 
Fig. 3:  
Effect of caffeine on the proliferation of ORSK - CyQUANT assay 
ORSK from 3 male donors were incubated with caffeine at different concentrations (0.00001%, 
0.0001%, 0.001%) and IGF-1 (100 ng/ml), minoxidil (0.1 µM) and tretinoin (1 µM) for 24, 48, 72 and 
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96 h, respectively. After 24 h incubation, caffeine significantly stimulated ORSK proliferation in all 
three concentrations, while after 48 h incubation only at the concentration of 0.0001%, and at later 
time points at no concentration. The effect size of stimulation exerted by caffeine at 24 h was 
superior to IGF-1 and minoxodil. IGF-1 significantly stimulated proliferation at 24, 47 and 72 h 
incubation time. Minoxidil stimulated ORSK proliferation only at 24 h incubation time and was 
inferior to the caffeine effect. The cell proliferative activity was evaluated by fluorimetric CyQUANT 
assay. Data are expressed as means ±SEM in comparison to the vehicle-treated control (=100%, solid 
line).   
 
Fig. 4:  
Effect of caffeine on the proliferation of ORSK - Ki67 immunofluorescence-cytochemistry. 
ORSK, obtained from 3 male donors, were treated by vehicle (Control) or various concentrations of 
caffeine for 24 hrs and showed a significant dose-dependent stimulation of proliferation by 
immunolabeling with the proliferation marker Ki67. A) Representative images of Ki67-positive ORSK 
of control and caffeine-treated (0.001%) samples. B) Evaluation of Ki67-positive keratinocyte 
percentage of keratinocytes in culture after 24 h caffeine incubation or vehicle treatment. The 
number of Ki67-positive cells was determined in 10 independent visual fields in each of the four 
groups of cell culture (control, caffeine), and the average mean ±SEM values are presented in 
comparison to the control (=100%, solid line). *p<0.05. 
 
Fig. 5:  
Effects of caffeine on preventing the cell death-promoting actions of TGF-β2 (A) and anandamide (B). 
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Combined fluorimetric DilC1(5)/SYTOX Green assays performed after 48 hrs treatment. Apoptosis is 
induced when the DilC1(5) signal intensity decreases whereas necrosis is induced when the Sytox 
Green signal intensity increases. Caffeine significantly counteracted apoptosis and necrosis in TGF-β2 
and AEA treated ORSK at the concentration of 0.0001% (only necrosis) and 0.001%. Data are 
expressed as mean ±SEM. *p<0.05 in comparison to the vehicle-treated controls (100%, dotted red 
lines). #p<0.05 in comparison to the TGF-β2 (A) or AEA (B) treated controls (solid blue lines). 
Experiments using cells from 2 other donors yielded similar results. 
 
 
Fig. 6:  
Hair cycle analysis of male and female hair follicles. 
The rate of anagen phase HFs was reduced by testosterone to 39% in male hair follicles and 
enhanced up to 70% by caffeine at 0.001% (A). In female HF, testosterone suppressed the rate of 
anagen phase HF to 55%, and caffeine enhanced anagen rate up to 65% (0.001%) and 63% (0.0005%) 
(B). Hair cycle score in male (C) and female (D) hair follicles: each HF was ascribed an arbitrary value 
corresponding to its histomorphologically detected hair cycle stage (anagen: 100; late anagen: 200; 
early catagen: 300; catagen: 400). The sum of values within one experimental condition was divided 
by the number n of evaluated hair follicles (control: n=37; testosterone: n=29; testosterone and 
caffeine: n=28). In male HF, a significant shift of hair cycle score to catagen was observed by 
testosterone and a back-shift towards anagen by caffeine 0.001%. In female HF, only testosterone 
induced a catagen-shift, while no effect of caffeine was observed. Data represent results from 
independent experiments from three different individuals and are presented as mean values ±SEM; 
*p<0.05; ** p<0.01. 
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Fig. 7:  
Modulation of in situ TGF-β2 protein expression by caffeine 
In male human hair follicles, testosterone induced a significant up-regulation of the catagen-inductor 
TGF-β2 up to 122.7% compared to 100% control (*p<0.05) (A,B). Caffeine 0.001% significantly 
reduced the TGF-β2 expression down to normal (control) levels (97.59%; **p<0.01). #1, #2 and #3 
are exemplary images of the different treatment conditions from the HF from one representative 
experiment; mean ±SEM; n=9-11. In female hair follicles, there was no relevant up-regulation of TGF-
β2 by testosterone, but a significant decrease induced by caffeine 0.0005% from 102.5% to 89.24% 
(p<0.01) (C,D). #1 and #2 show images of the different treatment conditions from the HF from two 
different individuals and are presented as mean values ±SEM; n=17-32; ORS: outer root sheath; He: 
Henle layer; 
 
Fig. 8: 
Modulation of in situ IGF-1 protein expression by caffeine 
IGF-1 IF-reactivity was detected in the outer root sheath (ORS), but also in the inner root sheath (IRS) 
(A,C). In male hair follicles, testosterone significantly reduced the expression of the growth factor 
IGF-1 (p<0.05), whereas co-cultivation with caffeine lead to a significant up-regulation of IGF-1 
expression compared to testosterone-incubated hair follicles (p<0.001), but also to hair follicles 
cultivated under normal conditions (control) (p<0.01) (B).  
#1, #2 and #3 are exemplary images of the different treatment conditions from the HF from two 
different individuals. Values are represented as means ±SEM; n=21-27. In female hair follicles, there 
was a stimulation of IGF-1 expression by the concentrations of 0.005% and 0.001% caffeine (C;D). 
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Data represent results from one experiment. Values are represented as means ±SEM; n=6-16; ORS: 
outer root sheath; IRS: inner root sheath; DP: dermal papilla; 
 
Fig. 9: 
Effects of caffeine, IGF-1, minoxidil and tretinoin on IGF-1 gene expression of ORSK. 
Q-PCR analysis of ORSK of 3 donors. Caffeine at the concentration 0.001% significantly up-regulated 
IGF-1 gene expression of ORSK in 2 donors and minoxidil (0.1 μM) significantly up-regulated IGF-1 
gene expression in all three donors (p<0.05) (Fig. 9A,B,C). The negative standard tretinoin (1 µM) 
had no influence on IGF-1 gene expression in any donor. Data are expressed as mean ±SEM. *p<0.05 
in comparison to the vehicle-treated control. 
 
Fig. 10: 
Effects of caffeine, IGF-1, minoxidil and tretinoin on TGF-β2 and IGF-1 protein secretion from ORSK. 
Caffeine significantly stimulated TGF-β2 protein secretion from ORSK after 120 h incubation with the 
concentration 0.001% (C), and the catagen inducer tretinoin enhanced TGF-β2 secretion at 72 and 
120 h (B,C). IGF-1 protein secretion was enhanced by caffeine at the concentration of 0.001% and by 
IGF-1 at all incubation times, 24 h (D), 72 h (E) and 120 h (F). Minoxidil had only a stimulatory effect 
on IGF-1 protein secretion at 120 h (F). Data are expressed as mean ±SEM. *p<0.05 in comparison to 
the vehicle-treated control. Experiments using cells from 2 other donors yielded similar results. 
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Fig. 1 
Hair shaft elongation in female human hair follicles 
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Fig 2 
Hair matrix keratinocyte proliferation 
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Fig 3 
Determination of cellular proliferation 
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Fig 4 
Immunofluorescence-cytochemical labeling of proliferation  
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Fig 5 
Determination of apoptosis and necrosis 
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Fig 6 
Hair cycle analysis 
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Fig 7 
Modulation of TGF-β2 protein expression in situ 
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Fig 8 
Modulation of IGF-1 protein expression in situ 
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Fig 9 
IGF-1 gene expression 
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Fig 10 
TGF-β2 (A-C) and IGF-1 (D-F) protein secretion 
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